Alfaro, Rosalie D.

HRN: 01-08-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2024
CEFTRIAXONE 1G (VIAL)
09/10/2024
09/17/2024
IV
1g
Q12
Spondylosis Disk Dessication L4- L5
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: